Unknown

Dataset Information

0

GLUT1 deficiency syndrome as a cause of encephalopathy that includes cognitive disability, treatment-resistant infantile epilepsy and a complex movement disorder.


ABSTRACT: Glucose transporter-1 (GLUT1) deficiency syndrome is caused by heterozygous mutations in the SLC2A1 gene, resulting in impaired glucose transport into the brain. It is characterized by a low glucose concentration in the cerebrospinal fluid (hypoglycorrhachia) in the absence of hypoglycemia, in combination with low to normal lactate in the cerebrospinal fluid (CSF). It often results in treatment-resistant infantile epilepsy with progressive developmental disabilities and a complex movement disorder. Recognizing GLUT1 deficiency syndrome is important, since initiation of a ketogenic diet can reduce the frequency of seizures and the severity of the movement disorder. There can be a considerable delay in diagnosing GLUT1 deficiency syndrome, and this point is illustrated by the natural history of this disorder in a 21-year-old woman with severe, progressive neurological disabilities. Her encephalopathy consisted of treatment-resistant seizures, a complex movement disorder, progressive intellectual disability, and deceleration of her head growth after late infancy. Focused evaluation at age 21 revealed GLUT1 deficiency caused by a novel heterozygous missence mutation in exon 7 (c.938C > A; p.Ser313Try) in SLC2A1 as the cause for her disabilities.

SUBMITTER: Graham JM 

PROVIDER: S-EPMC3439502 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

GLUT1 deficiency syndrome as a cause of encephalopathy that includes cognitive disability, treatment-resistant infantile epilepsy and a complex movement disorder.

Graham John M JM  

European journal of medical genetics 20111220 5


Glucose transporter-1 (GLUT1) deficiency syndrome is caused by heterozygous mutations in the SLC2A1 gene, resulting in impaired glucose transport into the brain. It is characterized by a low glucose concentration in the cerebrospinal fluid (hypoglycorrhachia) in the absence of hypoglycemia, in combination with low to normal lactate in the cerebrospinal fluid (CSF). It often results in treatment-resistant infantile epilepsy with progressive developmental disabilities and a complex movement disord  ...[more]

Similar Datasets

| S-EPMC3769928 | biostudies-literature
| S-EPMC5432661 | biostudies-literature
| S-EPMC8351430 | biostudies-literature
| S-EPMC4121475 | biostudies-literature
| S-EPMC3257886 | biostudies-literature
| S-EPMC6466106 | biostudies-literature
| S-EPMC6698685 | biostudies-literature
| S-EPMC4320260 | biostudies-literature
| S-EPMC4864756 | biostudies-literature
| S-EPMC5687290 | biostudies-literature